In GCA, treatment with GC therapy suppressed circulating Th17 but not Th1 cells and this paralleled a reduction in the concentration of cytokines promoting Th17 differentiation, such as IL-1β, IL-6 and IL-23, while levels of the Th1 cells producing IL-12 remained unaffected [94]. The gene discussed is IL6; the disease is temporal arteritis.